Healthcare AI Acquisition Corp.
HAIAW · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -12.41 | -0.90 | 0.81 | 0.00 |
| FCF Yield | -0.65% | -0.24% | -0.70% | -0.96% |
| EV / EBITDA | -103.29 | 37.28 | 20.79 | 11.05 |
| Quality | ||||
| ROIC | -14.87% | -18.81% | -0.54% | -1.22% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -7.85 | -0.09 | -0.14 | -0.24 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | -100.00% | -100.00% |
| Free Cash Flow Growth | -11.24% | 78.34% | 28.17% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -1.67 | 0.05 | -0.02 | -0.09 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |